Management of spasticity in cerebral palsy with botulinum-a toxin: Report of a preliminary, randomized, double-blind trial

Journal of Pediatric Orthopaedics

Volumn 14, Issue 3, 1994, Pages 299-

  Koman, L Andrew ^a   Mooney, James F ^a   Smith, Beth P ^a   Goodman, Amy ^a   Mulvaney, Theresa ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Botulinum A toxin; Cerebral palsy; Dynamic joint contracture; Spasticity

Indexed keywords

ACETYLCHOLINE; ALCOHOL; BOTULINUM TOXIN A; DIAZEPAM; PHENOL; PLACEBO;

ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FUNCTIONAL ASSESSMENT; GAIT; HUMAN; INJECTION PAIN; INJECTION SITE; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT CONTRACTURE; MULTICENTER STUDY; MUSCLE DENERVATION; MUSCLE WEAKNESS; PES EQUINUS; PHYSICIAN; PHYSIOTHERAPIST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEDATION; SKIN NECROSIS; SPASTICITY;

BOTULINUM TOXINS; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FOOT DEFORMITIES, ACQUIRED; GAIT; HUMANS; INJECTIONS, INTRAMUSCULAR; MUSCLE SPASTICITY; RANGE OF MOTION, ARTICULAR;

EID: 0028303018     PISSN: 02716798     EISSN: 15392570     Source Type: Journal    
DOI: 10.1097/01241398-199405000-00005     Document Type: Article

References (36)

1. Arthurs B, Flanders M, Codere F, Gauthier S, Dresner S, Stone L. Treatment of blepharospasm with medication, surgery and type-A botulinum toxin. Can J Ophthalmol 1987; 22:24-8.
2. Banks HH. Cerebral palsy. In: Lovell WW, Winter RB, eds. Pediatric Orthopaedics. Philadelphia: JB Lippincott, 1987: 329-79.
3. Bleck EE. Orthopaedic management in cerebral palsy. Clin Dev Med 1987;99/100:121-41.
4. Borodic GE, Cozzolino D. Blepharospasm and its treatment, with emphasis on the use of botulinum toxin. Plast Reconstr Surg 1989;83:546-54.
5. Brin MF, Fahn S, Moskowitz C, Friedman A, Shale HM, Greene PE, Blitzer A, List T, Lange D, Lovelace RE, Mc-Mahon D. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1987;2:237-54.
6. Carpenter EB. Role of nerve blocks in the foot and ankle in cerebral palsy: therapeutic and diagnostic. Foot Ankle 1983; 4:164-6.
7. Carpenter EB, Seitz DG. Intra-muscular alcohol as an aid in management of spastic cerebral palsy. Dev Med Child Neurol 1980;22:497-501.
8. Carruthers J, Stubbs HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm, and age-related lower eyelid entropion. Can J Neurol Sci 1987;14:42-5.
9. Diamond M. Rehabilitation strategies for the child with cerebral palsy. Pediatr Ann 1986;15:230-6.
10. Dolly JO, Black J, Williams RS, Melling J. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature 1984;307:457-60.
11. Drachman DB, Houk J. Effect of botulinum toxin on speed of skeletal muscle contraction. Am J Physiol 1969;216: 1453-5.
12. Duchen LW. Changes in the electron microscopic structure of slow and fast skeletal muscle fibres of the mouse after the local injection of botulinum toxin. J Neurol Sei 1971; 14:61-74.
13. Duthie RB, Bentley G. Neuromuscular affections in children. In: Mercer's orthopaedic surgery. Baltimore: University Park Press, 1983:396-421.
14. Dutton JJ, Buckley EG. Botulinum toxin in the management of blepharospasm. Arch Neurol 1986;43:380-2.
15. Dutton JJ, Buckley EG. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 1988;95:1529-34.
16. Elston JS. Botulinum toxin therapy for involuntary facial movement. Eye 1988;2:12-5.
17. Gelb DJ, Lowenstein DH, Aminoff MJ. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 1989;39:80-4.
18. Kao I, Drachman DB, Price DL. Botulinum toxin: mechanism of presynaptic blockage. Science 1976;193:1256-8.
19. Koman LA, Mooney JF III, Smith B, Goodman A, Mul-vaney T. Management of cerebral palsy with botulinum-A toxin. Preliminary investigation. J Pediatr Orthop 1993; 13: 489-95.
20. Kraft SP, Lang AE. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment including the use of botulinum toxin. Can Med Assoc J 1988;139:837-44.
21. Lamanna C, Carr CJ. The botulinal, tetanal, and entero-staphylococcal toxins: a review. Clin Pharmacol Ther 1967; 8:286-332.
22. Ludlow CL, Naunton RF, Sedory SE, Schulz GM, Hallet M. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology 1988;38:1220-5.
23. Meiling J, Hambleton P, Shone CC. Clostridium botulinum toxins: nature and preparation for clinical use. Eye 1988;2: 16-23.
24. Miller RH, Woodson GE, Jankovic J. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. Arch Otolaryngol Head Neck Surg 1987:113: 603-5.
25. Paneth N. Etiologic factors in cerebral palsy. Pediatr Ann 1986;15:191-201.
26. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980;87:1044-9.
27. Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 1981;79:734-70.
28. Scott AB, Kennedy RA, Stubbs HA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985;103:347-50.
29. Sellin LC. The action of botulinum toxin at the neuromuscular junction. Med Biol 1981;59:11-20.
30. Spector GJ. Letter to editor. Laryngoscope 1986;96:583.
31. Stell R, Thompson PD, Marsden CD. Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry 1988; 51:920-3.
32. Tardieu G, Tardieu C, Hariga J, Gagnard L. Treatment of spasticity by injection of dilute alcohol at the motor point or by epidural route. Clinical extension of an experiment on the decerebrate cat. Dev Med Child Neurol 1968;10:555-68.
33. Tsui JK, Eisen A, Mak E, Carruthers J, Scott A, Calne DB. A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sei 1985;12:314-6.
34. Tsui JKC, Eisen A, Calne DB. Botulinum toxin in spasmodic torticollis. Adv Neurol 1988;50:593-7.
35. Tsui JKC, Eisen A, Stoessl AJ, Calne S, Calne DB. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986;2:245-7.
36. Tsui JKC, Fross RD, Calne S, Calne DB. Local treatment of spasmodic torticollis with botulinum toxin. Can J Neurol Sei 1987;14:533-5.